DC
ABBV icon

Deschaine & Company’s AbbVie ABBV Stock Holding History

Deschaine & Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$995K Buy
14,815
+3,175
+27% +$207K 1.57% 20
2015
Q1 		$681K Buy
11,640
+30
+0.3% +$1.81K 1.12% 39
2014
Q4 		$760K Buy
+11,610
New +$732K 1.15% 37

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Deschaine & Company's ABBV Position: Q2 2015 in Review

Deschaine & Company increased its AbbVie (ABBV) stake by 27% in Q2 2015, buying an estimated $207K and bringing the position to 14,815 shares worth $995K. The position accounts for 1.57% of the portfolio, ranked #20.

Deschaine & Company first reported a position in ABBV in Q4 2014 and has held it in 3 quarters since. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

  • Deschaine & Company held 14,815 shares of AbbVie worth $995K as of Q2 2015.
  • Deschaine & Company bought 3,175 AbbVie shares in Q2 2015, an estimated $207K.
  • AbbVie made up 1.57% of Deschaine & Company's portfolio in Q2 2015, its #20 holding.
  • Deschaine & Company first reported a position in AbbVie in Q4 2014 and has held it in 3 quarters since.
  • 1,653 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Deschaine & Company's 13F filing for Q2 2015, filed 30 Jul 2015.